Singapore markets close in 4 hours 48 minutes

HLS Therapeutics Inc. (HLTRF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.9200+0.0200 (+0.69%)
At close: 12:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 89.79M
Enterprise value 155.44M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.54
Price/book (mrq)1.04
Enterprise value/revenue 2.56
Enterprise value/EBITDA 14.27

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-11.25%
S&P500 52-week change 327.84%
52-week high 34.9494
52-week low 32.6000
50-day moving average 33.3447
200-day moving average 33.3645

Share statistics

Avg vol (3-month) 3171
Avg vol (10-day) 3500
Shares outstanding 531.81M
Implied shares outstanding 633.4M
Float 816.47M
% held by insiders 10.49%
% held by institutions 159.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.15
Forward annual dividend yield 44.21%
Trailing annual dividend rate 30.08
Trailing annual dividend yield 32.62%
5-year average dividend yield 41.69
Payout ratio 40.00%
Dividend date 315 Jun 2023
Ex-dividend date 427 Apr 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -45.81%
Operating margin (ttm)-27.80%

Management effectiveness

Return on assets (ttm)-3.08%
Return on equity (ttm)-26.78%

Income statement

Revenue (ttm)60.79M
Revenue per share (ttm)1.88
Quarterly revenue growth (yoy)-15.50%
Gross profit (ttm)N/A
EBITDA 18.84M
Net income avi to common (ttm)-27.84M
Diluted EPS (ttm)-0.8600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.44M
Total cash per share (mrq)0.61
Total debt (mrq)88.94M
Total debt/equity (mrq)99.86%
Current ratio (mrq)1.56
Book value per share (mrq)2.77

Cash flow statement

Operating cash flow (ttm)12.55M
Levered free cash flow (ttm)21.07M